Literature DB >> 7537567

Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis.

A Schuster1, A Haarmann, V Wahn.   

Abstract

Bronchopulmonary disease in patients with cystic fibrosis (CF) is a paradigm of neutrophil-dominated airway inflammation. We hypothesized that proinflammatory cytokines contribute to a localized neutrophil-dominated inflammatory state as present in CF airways. In a cross-sectional study, we analyzed 63 sputum samples from 33 CF patients for concentrations of the cytokines interleukin-1 alpha (IL-1 alpha), IL-1 beta, IL-8, tumor necrosis factor-alpha (TNF-alpha), and granulocyte-colony stimulating factor (G-CSF) by means of enzyme-linked immunosorbent assay. Furthermore, the activity of neutrophil elastase (NE) in the sputum samples was determined using a specific chromogenic substrate. Compared to sputum samples from 10 healthy controls, there were significantly increased concentrations of IL-1 beta, IL-8 and TNF-alpha in the CF sputum samples. The concentration of IL-8 correlated significantly with NE activity in the CF sputum samples. In CF patients with airways chronically colonized with Pseudomonas aeruginosa, IL-8 concentrations in sputum were significantly enhanced. In glucocorticoid-treated patients, IL-1 alpha and G-CSF sputum concentrations were significantly lower when compared to levels in the other patients. These results show that there are high concentrations of proinflammatory cytokines in CF airways which may contribute to the localized neutrophil-dominated inflammatory state found clinically.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537567     DOI: 10.1007/bf02484436

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  5 in total

1.  Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.

Authors:  W Goldstein; G Döring
Journal:  Am Rev Respir Dis       Date:  1986-07

Review 2.  Neutrophil activation by recombinant cytokines.

Authors:  M J Steinbeck; J A Roth
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

3.  Corticosteroid treatment in cystic fibrosis.

Authors:  J F Price; P Greally
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

4.  Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases.

Authors:  J B Richman-Eisenstat; P G Jorens; C A Hébert; I Ueki; J A Nadel
Journal:  Am J Physiol       Date:  1993-04

5.  Interleukin 1 production by human lung tissue. I. Identification and characterization.

Authors:  B S Bochner; S D Landy; M Plaut; C A Dinarello; R P Schleimer
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

  5 in total
  12 in total

1.  The Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)homoserine lactone contributes to virulence and induces inflammation in vivo.

Authors:  Roger S Smith; Sarah G Harris; Richard Phipps; Barbara Iglewski
Journal:  J Bacteriol       Date:  2002-02       Impact factor: 3.490

2.  Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis.

Authors:  Florencia McAllister; Adam Henry; James L Kreindler; Patricia J Dubin; Lauren Ulrich; Chad Steele; Jonathan D Finder; Joseph M Pilewski; Beatriz M Carreno; Samuel J Goldman; Jaana Pirhonen; Jay K Kolls
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

3.  Superantigens and cystic fibrosis: resistance of presenting cells to dexamethasone.

Authors:  J Ben-Ari; D Gozal; R J Dorio; C M Bowman; A Reiff; S M Walker
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

4.  Evaluation of tumour necrosis factor-alpha and interleukin-1beta in an experimental pyelonephritis model induced with planktonic and biofilms cells of Pseudomonas aeruginosa.

Authors:  Rahul Mittal; Saroj Sharma; Sanjay Chhibber; Kusum Harjai
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

5.  Faster activation of polymorphonuclear neutrophils in resistant mice during early innate response to Pseudomonas aeruginosa lung infection.

Authors:  P Ø Jensen; C Moser; O Kobayashi; H P Hougen; A Kharazmi; N Høiby
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

6.  Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor.

Authors:  Nina Reiniger; Martin M Lee; Fadie T Coleman; Christopher Ray; David E Golan; Gerald B Pier
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

7.  Neutrophils in cystic fibrosis display a distinct gene expression pattern.

Authors:  Minou Adib-Conquy; Thierry Pedron; Anne-France Petit-Bertron; Olivier Tabary; Harriet Corvol; Jacky Jacquot; Annick Clément; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

Review 8.  Sputum biomarkers of inflammation in cystic fibrosis lung disease.

Authors:  Scott D Sagel; James F Chmiel; Michael W Konstan
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

Review 9.  Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target.

Authors:  Xiaoqing Guan; Yuning Hou; Fei Sun; Zhe Yang; Chunying Li
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

10.  Biochemical and Cellular Characterization and Inhibitor Discovery of Pseudomonas aeruginosa 15-Lipoxygenase.

Authors:  Joshua D Deschamps; Abiola F Ogunsola; J Brian Jameson; Adam Yasgar; Becca A Flitter; Cody J Freedman; Jeffrey A Melvin; Jason V M H Nguyen; David J Maloney; Ajit Jadhav; Anton Simeonov; Jennifer M Bomberger; Theodore R Holman
Journal:  Biochemistry       Date:  2016-06-03       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.